BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
MDM2
,
Fatty acid metabolic process
,
Obesity
,
Adipose tissue
,
Biofuel
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Polycomb Like 1
Summary
General Info
Curated Studies
Most Correlated Studies
Synovial sarcoma SY01, HSSY2 and Aska cells with SSX shRNA knockdown
Embryonic stem cell (ESC)-like cells with Prdm14 knockout treated with LIF-containing serum
Bone-marrow derived Very Small Embryonic-Like Stem Cells (VSELs)
Myeloma MM.1S cells with PHF19 shRNA knockdown rescued
Multiple myeloma ARP1 cells with shRNA-mediated PHF19 knockdown or with PHF19 overexpression
Explore Curated Studies Results
Literature
Most Relevant Literature
Structural basis for histone variant H3tK27me3 recognition by PHF1 and PHF19.
Vectored Intracerebral Immunization with the Anti-Tau Monoclonal Antibody PHF1 Markedly Reduces Tau …
Structures of AT8 and PHF1 phosphomimetic tau: Insights into the posttranslational modification code…
PHF1 compartmentalizes PRC2 via phase separation.
Discovery of an H3K36me3-Derived Peptidomimetic Ligand with Enhanced Affinity for Plant Homeodomain …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia
Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma Af…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ